Dr Bauml On Locally Ablative Therapy In Oligometastatic Nsclc

Joshua Bauml, MD, assistant professor, Perelman School of Medicine, University of Pennsylvania, discusses the use of locally ablative therapy in patients with oligometastatic non–small cell lung cancer.

  • Dr. Bauml on Locally Ablative Therapy in Oligometastatic NSCLC ( Download)
  • Dr. Bauml on the Use of Immunotherapy in Oligometastatic NSCLC ( Download)
  • Dr. Bauml on Treatment For Oligometastatic NSCLC ( Download)
  • Pembrolizumab as Treatment for Oligometastatic NSCLC ( Download)
  • Managing Oligometastases With Ablative Therapy in NSCLC ( Download)
  • Dr. Mix on Local Consolidative Therapy in Oligometastatic NSCLC ( Download)
  • Radical treatment for oligometastatic NSCLC ( Download)
  • Dr. Bauml on Emerging Biomarkers in NSCLC ( Download)
  • GRACEcast - Emerging Molecular Targets in NSCLC- MET with Dr. Josh Bauml ( Download)
  • Dr. Choy Discusses Therapy for Oligometastatic Lung Cancer ( Download)
  • GRACEcast - Emerging Molecular Targets in NSCLC- RET Fusions with Dr. Josh Bauml ( Download)
  • Lung Cancer Video Library 2020 - BAUML - Emerging Molecular Targets in NSCLC MET ( Download)
  • Dr. Bauml on a New Platform to Enhance Lung Cancer Clinical Trial Enrollment ( Download)
  • World Cancer Day with Dr. Bauml ( Download)
  • Dr. Urbanic on the Role of Radiotherapy in Oligometastatic NSCLC ( Download)